Hinge Health, Inc. (NYSE: HNGE) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
Latest market price
91.39
+2.07+2.31%
News
Up 2.3% — Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks (zacks.com).
Medium confidence
TA
Loading chart...
Snapshot
| Index | - | P/E | 66.34 | EPS (ttm) | 1.35 | Insider Own | - | Shs Outstand | 77.38M | Perf Week | 19.57% |
| Market Cap | 6.91B | Forward P/E | 28.56 | EPS next Y | 3.13 | Insider Trans | -6.66% | Shs Float | 73.37M | Perf Month | -0.66% |
| Enterprise Value | 6.63B | PEG | 0.87 | EPS next Q | - | Inst Own | - | Short Float | 8.50% | Perf Quarter | 62.42% |
| Income | 107.14M | P/S | 9.60 | EPS this Y | 135.08% | Inst Trans | - | Short Ratio | 3.39 | Perf Half Y | 181.00% |
| Sales | 720.06M | P/B | 20.44 | EPS next Y | 34.69% | ROA | 13.18% | Short Interest | 6.23M | Perf YTD | 92.31% |
| Book/sh | - | P/C | 24.21 | EPS next 5Y | 30.14% | ROE | 30.25% | 52W High | 93.61 -2.37% | Perf Year | 47.53% |
| Cash/sh | - | P/FCF | 24.06 | EPS past 3/5Y | - | ROIC | 26.29% | 52W Low | 30.78 196.97% | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 64.45 | Sales past 3/5Y | - | Gross Margin | 84.52% | Volatility | 8.94% 5.57% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 9.21 | EPS Y/Y TTM | -4313.33% | Oper. Margin | 13.01% | ATR (14) | 4.89 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.30 | Sales Y/Y TTM | 65.64% | Profit Margin | 15.15% | RSI (14) | 68.35 | Recom | 2.06 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.34 | EPS Q/Q | 112.06% | SMA20 | 10.16% | Beta | 1.09 | Target Price | 95.38 |
| Payout | 0.00% | Debt/Eq | 0.02 | Sales Q/Q | 46.77% | SMA50 | 18.46% | Rel Volume | 1.32 | Prev Close | 89.33 |
| Employees | 143 | LT Debt/Eq | 0.01 | Earnings | Nov 03 | SMA200 | 70.04% | Avg Volume | 1.93M | Price | 91.39 |
| IPO Date | May 22, 2025 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 13.27% 5.87% | Net Debt/EBITDA | -2.72 | Volume | 2,546,049 | Change | 2.31% |
Analyst Ratings
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-05-26 | Reiterated | Canaccord Genuity | Buy | $100 → $105 |
| Aug-05-26 | Reiterated | Stifel Nicolaus | $90 → $96 | |
| Aug-05-26 | Reiterated | Barclays | Overweight | $97 → $100 |
| Aug-05-26 | Reiterated | RBC Capital | Outperform | $75 → $110 |
| Aug-05-26 | Reiterated | Evercore ISI Group | Outperform | $45 → $105 |
| Jul-27-26 | Reiterated | Stifel Nicolaus | $79 → $90 | |
| Jul-21-26 | Reiterated | Canaccord Genuity | Buy | $76 → $100 |
| Jul-13-26 | Reiterated | Morgan Stanley | Overweight | $46 → $108 |
| Jul-13-26 | Reiterated | Barclays | Overweight | $70 → $97 |
| Jul-13-26 | Reiterated | Keybanc | Overweight | $90 → $125 |
Latest News
Today
Aug-06-26
Aug-05-26
03:04AM
Hinge Health Q2 Earnings Call Highlightsmarketbeat.com
01:00AM
Hinge Health, Inc. (HNGE) Q2 2026 Earnings Call Transcriptseekingalpha.com
Aug-04-26
04:05PM
04:05PM
Jul-30-26
Jul-30-2610:00AM
Jul-28-26
Jul-28-2611:06AM
Jul-27-26
Jul-27-2608:39AM
Jul-21-26
Jul-21-2607:10PM
01:00PM
Company
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Ownership
Per-holder 13F data hasn't been ingested for this ticker yet.
Financial Statements
DataTimeframe
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | |
|---|---|---|---|---|---|
| Total Revenue | 720 | 588 | 390 | — | |
| Cost of Goods Sold Incl. D&A | 112 | 119 | 90 | — | |
| Gross Profit | 608 | 469 | 301 | — | |
| Selling, General and Administrative Excl. Other | 384 | 639 | 228 | — | |
| Research and Development | 129 | 368 | 101 | — | |
| Other Operating Expense | 2 | 9 | 4 | — | |
| Operating Income | 93 | -546 | -32 | — | |
| Interest Expense | 0 | 0 | 0 | — | |
| Unusual Expense | — | — | — | — | |
| Non-Operating Income (Expense) | 17 | 19 | 21 | — | |
| Net Income Before Taxes | 110 | -527 | -11 | — | |
| Income Taxes | 2 | 1 | 1 | — | |
| Consolidated Net Income | 109 | -528 | -12 | — | |
| Net Income From Continuing Operations | 109 | -528 | -12 | — | |
| Net Income | 109 | -528 | -12 | — | |
| EPS (Recurring) | 1.35 | -5.36 | -0.15 | — | |
| EPS (Basic, Before Extraordinaries) | 1.35 | -5.36 | -0.15 | — | |
| EPS (Diluted) | 1.29 | -5.19 | -0.15 | — | |
| EBITDA | 102 | -536 | -22 | — | |
| Other After Tax Adjustments | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | |
| Price To Earnings Ratio | 70.85 | — | — | — | |
| Price To Sales Ratio | 10.03 | 6.24 | — | — | |
| Gross Margin | 84.44 | 79.76 | 77.18 | — | |
| Operating Margin | 12.92 | -92.86 | -8.21 | — | |
| Net Margin | 15.14 | -89.80 | -3.08 | — | |
| Shares Outstanding | 79 | 79 | 78 | — | |
| Market Capitalization | 7,220 | 3,670 | — | — | |
| Operating Lease Expense | — | — | — | — |
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
Insider Trading
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Mecklenburg Gabriel M.I. | director, other: Exec. Chairman & Co-Founder | Aug 04 '26 | Option Exercise | 0.00 | 944,250 | 0 | 2,588,257 | Aug 06 |
| Perez Daniel Antonio | CEO & Co-Founder | Jul 27 '26 | Option Exercise | 0.00 | 944,250 | 0 | 10,433,095 | Jul 29 |
| Insight Holdings Group, LLC | 10% Owner | Jul 09 '26 | Sale | 90.18 | 176,352 | 15,902,732 | 0 | Jul 09 |
| Insight Holdings Group, LLC | 10% Owner | Jul 07 '26 | Sale | 90.23 | 19,382 | 1,748,766 | 0 | Jul 09 |
| Mecklenburg Gabriel M.I. | director, other: Exec. Chairman & Co-Founder | Jul 01 '26 | Sale | 85.05 | 83,334 | 7,087,529 | 0 | Jul 02 |
| Insight Holdings Group, LLC | 10% Owner | Jun 29 '26 | Sale | 82.83 | 1,466,023 | 121,434,855 | 0 | Jun 29 |
| Insight Holdings Group, LLC | 10% Owner | Jun 25 '26 | Sale | 71.74 | 499,661 | 35,844,517 | 0 | Jun 29 |
| Insight Holdings Group, LLC | 10% Owner | Jun 24 '26 | Sale | 70.91 | 265,107 | 18,798,311 | 0 | Jun 24 |
| Insight Holdings Group, LLC | 10% Owner | Jun 23 '26 | Sale | 70.21 | 8,910 | 625,611 | 0 | Jun 24 |
| Insight Holdings Group, LLC | 10% Owner | Jun 22 '26 | Sale | 70.78 | 130,042 | 9,203,852 | 0 | Jun 24 |
| Pursley James | President | Jun 22 '26 | Sale | 69.31 | 33,000 | 2,287,252 | 740,897 | Jun 23 |
| Insight Holdings Group, LLC | 10% Owner | Jun 16 '26 | Sale | 70.36 | 5,195 | 365,518 | 0 | Jun 18 |
| Robinson Elliott | Director | Jun 12 '26 | Sale | 0.00 | 0 | 0 | 0 | Jun 12 |
| Mecklenburg Gabriel M.I. | director, other: Exec. Chairman & Co-Founder | Jun 05 '26 | Sale | 65.54 | 50,000 | 3,276,843 | 0 | Jun 05 |
| Robinson Elliott | Director | Jun 02 '26 | Sale | 0.00 | 0 | 0 | 0 | Jun 03 |
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.